Diagnostic Hybrids Receives Approval From Chinese SFDA For D3(R) Ultra™ DFA Respiratory Virus Screening And ID Kit

Main Category: Respiratory / Asthma
Also Included In: Regulatory Affairs / Drug Approvals;  Infectious Diseases / Bacteria / Viruses
Article Date: 07 Jul 2010 - 1:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:not yet rated

Healthcare Prof:not yet rated


Diagnostic Hybrids, a Quidel Company (NASDAQ:QDEL), received approval from the People's Republic of China's State Food and Drug Administration (SFDA) for its D3 Ultra DFA Respiratory Virus Screening and ID Kit. The D3 Ultra DFA Respiratory Virus Screening and ID Kit is a direct fluorescence assay (DFA) that provides rapid, sensitive and specific screening and identification of Influenza A, Influenza B, Parainfluenza 1, 2, & 3, Respiratory Syncytial Virus and Adenovirus.

"This clearance marks an important milestone in our international expansion strategy," said Douglas Bryant, president and chief executive officer of Quidel Corporation. "The D3 Ultra DFA Respiratory Virus Screening and ID Kit is an established market leader in the United States clinical virology testing market. With this approval to commercialize the kit in China, we expect similar longer-term success in a market that has the potential to be as large as the U.S. respiratory virus testing segment."

"This is important news for healthcare professionals in China," stated David Scholl, Ph.D., senior vice president, commercial operations and president of Diagnostic Hybrids. "Many laboratories in emerging markets find that molecular-based equipment and reagent costs are prohibitive. D3 Ultra will give labs in China a cost-effective alternative for detecting multiple respiratory viruses that is fast, reliable and accurate."

The D3 Ultra DFA Respiratory Virus Screening and ID Kit can be used in direct testing of patient specimens with results in as fast as 15 minutes, or in cell culture with the patented R-MixTM and R-Mix TooTM Mixed FreshCellsTM cell culture systems within 24-48 hours.

Source:
Quidel Corporation

Article adapted by Medical News Today from original press release.
Visit our respiratory / asthma section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
Diagnostic Hybrids. "Diagnostic Hybrids Receives Approval From Chinese SFDA For D3(R) Ultra™ DFA Respiratory Virus Screening And ID Kit." Medical News Today. MediLexicon, Intl., 7 Jul. 2010. Web.
16 Feb. 2012. <http://www.medicalnewstoday.com/releases/193945.php>

APA
Diagnostic Hybrids. (2010, July 7). "Diagnostic Hybrids Receives Approval From Chinese SFDA For D3(R) Ultra™ DFA Respiratory Virus Screening And ID Kit." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/193945.php.

Please note: If no author information is provided, the source is cited instead.


Respiratory / Asthma

What is Asthma?

Asthma is a disease affecting the airways that carry air to and from your lungs. People who suffer from this chronic condition (long-lasting or recurrent) are said to be asthmatic. Read more...

Most Popular Articles



Follow Our Respiratory News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Respiratory / Asthma Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »